Advanced Health Intelligence Ltd
AHI was delisted on the 31st of January, 2024.
3 hedge funds and large institutions have $7.39K invested in Advanced Health Intelligence Ltd in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
0% more capital invested
Capital invested by funds: $7.38K → $7.39K (+$12)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$12 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $4.39K | +$12 | +8 | +0.3% |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $2.95K | – | – | – |
|
3
Qube Research & Technologies (QRT)
London,
United Kingdom
| $57 | – | – | – |
|
AHI Hedge Fund Activity: Q2 2024 in Review
3 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Advanced Health Intelligence Ltd (AHI) for Q2 2024, worth a combined $7.39K — up 0.16% from $7.38K a quarter earlier.
Fund positioning in AHI was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $12.
- 3 institutional investors held Advanced Health Intelligence Ltd (AHI) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $7.39K of Advanced Health Intelligence Ltd stock for Q2 2024, up 0.16% quarter-over-quarter.
- 0 funds opened new Advanced Health Intelligence Ltd positions in Q2 2024 and 0 closed out.
- The largest Advanced Health Intelligence Ltd buyer in Q2 2024 was Morgan Stanley, an estimated $12 added.
Based on aggregated 13F filings for Q2 2024.